Maxwell Hubert Antwi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maxwell Hubert Antwi has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Ansumana Bockarie
University of Cape Coast
5 shared publications - David Larbi Simpong
Department of Medical Laboratory Science School of Allied Health Sciences University of Cape Coast Cape Coast Ghana
5 shared publications - David Mawutor Donkor
Department of Medical Laboratory Science School of Allied Health Sciences University of Cape Coast Cape Coast Ghana
5 shared publications - George Nkrumah Osei
Department of Medical Laboratory Science School of Allied Health Sciences University of Cape Coast Cape Coast Ghana
5 shared publications - Linus Kpelle
Department of Medical Laboratory Science School of Allied Health Sciences University of Cape Coast Cape Coast Ghana
3 shared publications - Tonnies Abeku Buckman
Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
3 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (4) , e71326
Parasitic Infections and Associated Cognitive Outcome Among School‐Aged Children in Africa: A Systematic Review
Background: Parasitic infections remain endemic among children, yet the neurocognitive and educational impact of these infections has not been systematically synthesized. This systematic review investigates the potential associations between parasitic infections and neurocognitive and educational outcomes among school‐aged children. Methods: A comprehensive review was conducted in accordance with PRISMA guidelines. Included studies encompassed both observational and interventional designs, examining cognitive and educational outcomes in relation to infections with Schistosoma spp., soil‐transmitted helminths (STHs), Plasmodium spp., and other common parasitic agents. Results: Of the 80 studies reviewed, 29 focused on Schistosoma spp., with 13 identifying significant cognitive impairments, particularly in memory, attention, and increased school absenteeism. STHs were investigated in 26 studies, 11 of which reported associations with reduced intelligence quotient (IQ), executive dysfunction, and poor academic performance. Plasmodium spp. was examined in 15 studies, with 9 highlighting cognitive deficits, especially postcerebral malaria. Additional parasitic infections, including tungiasis (3 studies), Giardia and Entamoeba spp. (4 studies), and Taenia spp. (2 studies), were consistently linked to adverse cognitive and educational outcomes. Conclusion: The most frequently implicated parasites are Schistosoma spp., STHs, and Plasmodium spp. demonstrate consistent associations with neurocognitive deficits. Pharmacological treatment alone may be insufficient; comprehensive strategies integrating early medical intervention, nutritional rehabilitation, and improved educational access are warranted. Future research should emphasize longitudinal methodologies, harmonized cognitive assessment tools, and cross‐sectoral approaches to mitigate these developments.
- 30 March 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (4) , e71326
Open AccessParasitic Infections and Associated Cognitive Outcome Among School‐Aged Children in Africa: A Systematic Review
Background: Parasitic infections remain endemic among children, yet the neurocognitive and educational impact of these infections has not been systematically synthesized. This systematic review investigates the potential associations between parasitic infections and neurocognitive and educational outcomes among school‐aged children. Methods: A comprehensive review was conducted in accordance with PRISMA guidelines. Included studies encompassed both observational and interventional designs, examining cognitive and educational outcomes in relation to infections with Schistosoma spp., soil‐transmitted helminths (STHs), Plasmodium spp., and other common parasitic agents. Results: Of the 80 studies reviewed, 29 focused on Schistosoma spp., with 13 identifying significant cognitive impairments, particularly in memory, attention, and increased school absenteeism. STHs were investigated in 26 studies, 11 of which reported associations with reduced intelligence quotient (IQ), executive dysfunction, and poor academic performance. Plasmodium spp. was examined in 15 studies, with 9 highlighting cognitive deficits, especially postcerebral malaria. Additional parasitic infections, including tungiasis (3 studies), Giardia and Entamoeba spp. (4 studies), and Taenia spp. (2 studies), were consistently linked to adverse cognitive and educational outcomes. Conclusion: The most frequently implicated parasites are Schistosoma spp., STHs, and Plasmodium spp. demonstrate consistent associations with neurocognitive deficits. Pharmacological treatment alone may be insufficient; comprehensive strategies integrating early medical intervention, nutritional rehabilitation, and improved educational access are warranted. Future research should emphasize longitudinal methodologies, harmonized cognitive assessment tools, and cross‐sectoral approaches to mitigate these developments.
- Open Access
- 11 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3) , e72085
Plasmodium Parasitemia and Its Relationship With Hematological, Liver, and Kidney Function of Patients With Falciparum Malaria in the Eastern Region, Ghana
Background: Malaria remains a significant public health challenge in Sub‐Saharan Africa, including Ghana. Children and adults present with varying clinical and biochemical pictures in response to Plasmodium infection. Thus, the study aimed to explore the relationship between Plasmodium parasitemia and hematological, liver, and kidney function of children and adult participants, highlighting possible variations. Method: The cross‐sectional study was conducted in a public and a private health facility in the Eastern Region of Ghana from August 2023 to September 2023. Participants of the study comprised children under 5 years and adults 18 years and above. Structured questionnaires were used to gather participants' demographic information and medical history. Blood samples of participants were analyzed with standard microscopy technique for Plasmodium parasites. Hematological and biochemical parameters were also measured with fully automated hematology and chemistry analyzers, respectively. Data were analyzed using IBM SPSS Version 22. χ 2 analysis was performed to determine if differences in the degree of Plasmodium parasitemia and some demographic characteristics were significant. Kruskal–Wallis and post‐hoc pairwise tests were used to determine differences in hematological and biochemical parameters across categories of Plasmodium parasitemia. Statistical significance was assumed at a p value < 0.05. Results: The study enrolled 362 participants, comprising of 71.8% (260/362) adults and 69.3% (251/362) females. No significant differences were observed among gender and age categories across parasitemia levels, although a higher proportion of children < 5 years (51.9%, 53/102) recorded high parasitemia. Adult participants with high parasitemia recorded significantly lower Hb, RBC, MCV, MCH and PLT but higher ALT and AST than those with lower and moderate parasitemia. However, there was no significant variations in urea and creatinine levels with regard to degree of parasitemia among the participants. Conclusion: High Plasmodium parasitemia was linked with significant hematological and hepatic alterations, with distinct variations between adults and children < 5. The alterations observed in patients with high parasitemia highlight the importance of frequent and routine monitoring of these patients to address potential dysfunction early to prevent severe complications.
- 11 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3) , e72085
Open AccessPlasmodium Parasitemia and Its Relationship With Hematological, Liver, and Kidney Function of Patients With Falciparum Malaria in the Eastern Region, Ghana
Background: Malaria remains a significant public health challenge in Sub‐Saharan Africa, including Ghana. Children and adults present with varying clinical and biochemical pictures in response to Plasmodium infection. Thus, the study aimed to explore the relationship between Plasmodium parasitemia and hematological, liver, and kidney function of children and adult participants, highlighting possible variations. Method: The cross‐sectional study was conducted in a public and a private health facility in the Eastern Region of Ghana from August 2023 to September 2023. Participants of the study comprised children under 5 years and adults 18 years and above. Structured questionnaires were used to gather participants' demographic information and medical history. Blood samples of participants were analyzed with standard microscopy technique for Plasmodium parasites. Hematological and biochemical parameters were also measured with fully automated hematology and chemistry analyzers, respectively. Data were analyzed using IBM SPSS Version 22. χ 2 analysis was performed to determine if differences in the degree of Plasmodium parasitemia and some demographic characteristics were significant. Kruskal–Wallis and post‐hoc pairwise tests were used to determine differences in hematological and biochemical parameters across categories of Plasmodium parasitemia. Statistical significance was assumed at a p value < 0.05. Results: The study enrolled 362 participants, comprising of 71.8% (260/362) adults and 69.3% (251/362) females. No significant differences were observed among gender and age categories across parasitemia levels, although a higher proportion of children < 5 years (51.9%, 53/102) recorded high parasitemia. Adult participants with high parasitemia recorded significantly lower Hb, RBC, MCV, MCH and PLT but higher ALT and AST than those with lower and moderate parasitemia. However, there was no significant variations in urea and creatinine levels with regard to degree of parasitemia among the participants. Conclusion: High Plasmodium parasitemia was linked with significant hematological and hepatic alterations, with distinct variations between adults and children < 5. The alterations observed in patients with high parasitemia highlight the importance of frequent and routine monitoring of these patients to address potential dysfunction early to prevent severe complications.
- Open Access
- 1 January 2026
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 18 (1)
Population disparities in Alzheimer's disease: A systematic review of fluid and neuroimaging biomarkers
Alzheimer's disease manifests differently across ancestral groups, with African populations showing distinct fluid biomarker levels, neuroimaging patterns, and post mortem pathology. These differences may compromise diagnostic accuracy and exacerbate health disparities. This systematic review, examined studies published from 2015 to 2025 assessing amyloid‐β and tau via fluid assays and neuroimaging. Findings reveal ancestry‐linked variation where African populations exhibit lower cerebrospinal fluid/plasma Aβ42/Aβ40 and p‐tau181 ratios, with neuroimaging showing broadly similar reduced positron emission tomography patterns but slightly elevated amyloid and reduced tau signals. Limited post mortem data suggest reduced plaque and tangle densities despite comparable dementia severity. Genetic, environmental, and sociocultural factors contribute to these disparities. Diagnostic thresholds derived from non‐African cohorts risk underdiagnosing AD in African individuals. There is an urgent need to recalibrate and validate biomarker protocols to ensure equitable and accurate dementia diagnosis across diverse populations.
- 1 January 2026
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 18 (1)
Open AccessPopulation disparities in Alzheimer's disease: A systematic review of fluid and neuroimaging biomarkers
Alzheimer's disease manifests differently across ancestral groups, with African populations showing distinct fluid biomarker levels, neuroimaging patterns, and post mortem pathology. These differences may compromise diagnostic accuracy and exacerbate health disparities. This systematic review, examined studies published from 2015 to 2025 assessing amyloid‐β and tau via fluid assays and neuroimaging. Findings reveal ancestry‐linked variation where African populations exhibit lower cerebrospinal fluid/plasma Aβ42/Aβ40 and p‐tau181 ratios, with neuroimaging showing broadly similar reduced positron emission tomography patterns but slightly elevated amyloid and reduced tau signals. Limited post mortem data suggest reduced plaque and tangle densities despite comparable dementia severity. Genetic, environmental, and sociocultural factors contribute to these disparities. Diagnostic thresholds derived from non‐African cohorts risk underdiagnosing AD in African individuals. There is an urgent need to recalibrate and validate biomarker protocols to ensure equitable and accurate dementia diagnosis across diverse populations.
- Open Access
- 8 October 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (10) , e70769
Diagnostic potential of near‐infrared spectroscopy in mild cognitive impairment and neurodegenerative disorders: Implications for resource‐limited settings
BACKGROUND: Near‐infrared spectroscopy (NIRS) is emerging as a promising tool for early detection of mild cognitive impairment (MCI) and neurodegenerative diseases, especially where advanced imaging is limited. METHODOLOGY: This systematic review investigates NIRS's diagnostic capabilities. Adhering to Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, we conducted a comprehensive review of studies using NIRS for cognitive assessment in MCI and neurodegenerative conditions. RESULTS/DISCUSSION: NIRS effectively assesses cognitive function, identifying reduced prefrontal connectivity in MCI and subjective cognitive decline (SCD). Interestingly, while SCD patients maintain stronger brain network integrity, NIRS reveals decreased oxyhemoglobin levels in Alzheimer's disease (AD) patients’ dorsolateral prefrontal cortex. Combining NIRS with graph analysis, cognitive tasks, and machine learning significantly boosts diagnostic accuracy. Moreover, NIRS can differentiate between neurodegenerative disorders and, with concurrent electroencephalography, offers enhanced understanding of brain connectivity issues in AD. Our findings emphasize NIRS's considerable potential to improve cognitive assessment and neurodegeneration diagnosis. Highlights: Mild cognitive impairment (MCI) individuals show disruptions in neurovascular coupling and functional connectivity, particularly in the dorsolateral prefrontal cortex during near‐infrared spectroscopy (NIRS) assessments. Significant reductions in oxyhemoglobin (HbO 2 ) levels are observed in the dorsolateral prefrontal cortex of amnestic MCI (aMCI) individuals compared to healthy controls. Individuals with subjective cognitive decline (SCD) show lower HbO 2 levels than healthy individuals, while aMCI individuals show even more pronounced reductions. The dorsolateral prefrontal cortex is identified as a critical area for Alzheimer's disease (AD) assessment using NIRS, correlating with cognitive performance. Differences in Broca's area activation during language tasks help distinguish behavioral variant frontotemporal dementia from AD, revealing unique cognitive profiles through NIRS.
- 8 October 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (10) , e70769
Open AccessDiagnostic potential of near‐infrared spectroscopy in mild cognitive impairment and neurodegenerative disorders: Implications for resource‐limited settings
BACKGROUND: Near‐infrared spectroscopy (NIRS) is emerging as a promising tool for early detection of mild cognitive impairment (MCI) and neurodegenerative diseases, especially where advanced imaging is limited. METHODOLOGY: This systematic review investigates NIRS's diagnostic capabilities. Adhering to Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, we conducted a comprehensive review of studies using NIRS for cognitive assessment in MCI and neurodegenerative conditions. RESULTS/DISCUSSION: NIRS effectively assesses cognitive function, identifying reduced prefrontal connectivity in MCI and subjective cognitive decline (SCD). Interestingly, while SCD patients maintain stronger brain network integrity, NIRS reveals decreased oxyhemoglobin levels in Alzheimer's disease (AD) patients’ dorsolateral prefrontal cortex. Combining NIRS with graph analysis, cognitive tasks, and machine learning significantly boosts diagnostic accuracy. Moreover, NIRS can differentiate between neurodegenerative disorders and, with concurrent electroencephalography, offers enhanced understanding of brain connectivity issues in AD. Our findings emphasize NIRS's considerable potential to improve cognitive assessment and neurodegeneration diagnosis. Highlights: Mild cognitive impairment (MCI) individuals show disruptions in neurovascular coupling and functional connectivity, particularly in the dorsolateral prefrontal cortex during near‐infrared spectroscopy (NIRS) assessments. Significant reductions in oxyhemoglobin (HbO 2 ) levels are observed in the dorsolateral prefrontal cortex of amnestic MCI (aMCI) individuals compared to healthy controls. Individuals with subjective cognitive decline (SCD) show lower HbO 2 levels than healthy individuals, while aMCI individuals show even more pronounced reductions. The dorsolateral prefrontal cortex is identified as a critical area for Alzheimer's disease (AD) assessment using NIRS, correlating with cognitive performance. Differences in Broca's area activation during language tasks help distinguish behavioral variant frontotemporal dementia from AD, revealing unique cognitive profiles through NIRS.
- Open Access
- 25 July 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (7) , e70514
Cytokines and immune biomarkers in neurodegeneration and cognitive function: A systematic review among individuals of African ancestry
BACKGROUND: Cytokines and immune markers are critical in mediating inflammation associated with neurodegenerative disease. This review analyzes the role of inflammatory cytokines and immune markers in neurodegeneration among African populations. METHODS: Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, we conducted a systematic review of studies examining cytokine levels in neurodegenerative diseases, focusing on populations of African ancestry. RESULTS: Cytokines like interleukin (IL)‐6, soluble tumor necrosis factor receptor 1, plasma brain‐derived neurotrophic factor, and IL‐8. IL‐6 emerged as a key pro‐inflammatory marker linked to neurodegenerative diseases and cognitive decline, showing stronger correlations in African ancestry populations compared to Caucasians. Genetic findings revealed triggering receptor expressed on myeloid cells 2 variants and Fc fragment of IgG receptor IIb rs1050501 genotypes as influential in Alzheimer's disease (AD)‐related inflammation, alongside a unique correlation between immunoglobulin G index inflammatory markers and AD in African ancestry populations. DISCUSSION: The findings emphasize the crucial role of cytokines in the pathophysiology of neurodegenerative diseases. Understanding their variations among African populations can inform targeted therapeutic strategies and improve patient outcomes. Highlights: Interleukin (IL)‐6 was identified as a key pro‐inflammatory marker, consistently linked to Alzheimer's disease (AD), Parkinson's disease, and dementia, underscoring its significant role in neurodegenerative disease progression. Brain‐derived neurotrophic factor levels were associated with improved cognitive performance, particularly in African American participants. Observational studies identified sex‐based differences in IL‐10 levels, particularly among older African American women. The review highlights notable ethnic differences in cytokines like IL‐8, IL‐1β, and soluble tumor necrosis factor receptors, emphasizing their roles in neurodegeneration and cognitive decline in people of African descent. Triggering receptor expressed on myeloid cells 2 variants, immunoglobulin GM allotypes, and Fc fragment of IgG receptor IIb rs1050501 genotypes were found to influence AD‐related inflammation and progression in African ancestry populations.
- 25 July 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (7) , e70514
Open AccessCytokines and immune biomarkers in neurodegeneration and cognitive function: A systematic review among individuals of African ancestry
BACKGROUND: Cytokines and immune markers are critical in mediating inflammation associated with neurodegenerative disease. This review analyzes the role of inflammatory cytokines and immune markers in neurodegeneration among African populations. METHODS: Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, we conducted a systematic review of studies examining cytokine levels in neurodegenerative diseases, focusing on populations of African ancestry. RESULTS: Cytokines like interleukin (IL)‐6, soluble tumor necrosis factor receptor 1, plasma brain‐derived neurotrophic factor, and IL‐8. IL‐6 emerged as a key pro‐inflammatory marker linked to neurodegenerative diseases and cognitive decline, showing stronger correlations in African ancestry populations compared to Caucasians. Genetic findings revealed triggering receptor expressed on myeloid cells 2 variants and Fc fragment of IgG receptor IIb rs1050501 genotypes as influential in Alzheimer's disease (AD)‐related inflammation, alongside a unique correlation between immunoglobulin G index inflammatory markers and AD in African ancestry populations. DISCUSSION: The findings emphasize the crucial role of cytokines in the pathophysiology of neurodegenerative diseases. Understanding their variations among African populations can inform targeted therapeutic strategies and improve patient outcomes. Highlights: Interleukin (IL)‐6 was identified as a key pro‐inflammatory marker, consistently linked to Alzheimer's disease (AD), Parkinson's disease, and dementia, underscoring its significant role in neurodegenerative disease progression. Brain‐derived neurotrophic factor levels were associated with improved cognitive performance, particularly in African American participants. Observational studies identified sex‐based differences in IL‐10 levels, particularly among older African American women. The review highlights notable ethnic differences in cytokines like IL‐8, IL‐1β, and soluble tumor necrosis factor receptors, emphasizing their roles in neurodegeneration and cognitive decline in people of African descent. Triggering receptor expressed on myeloid cells 2 variants, immunoglobulin GM allotypes, and Fc fragment of IgG receptor IIb rs1050501 genotypes were found to influence AD‐related inflammation and progression in African ancestry populations.
- Open Access
- 28 April 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (4)
Genetic and environmental risk factors for dementia in African adults: A systematic review
Dementia, a leading cause of global mortality, disproportionately impacts sub‐Saharan Africans due to complex genetic and environmental interactions. This systematic review evaluated dementia risk factors among sub‐Saharan Africans, identifying significant genetic and environmental influences using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. The ATP‐binding cassette subfamily A member 7 (ABCA7) gene, linked to dementia in African Americans, and unique genetic variants like those in A‐kinase anchor protein 9 (AKAP9) and cytidine deaminase (CDA) genes, emerge as potential contributors. Conversely, apolipoprotein E (APOE) ε4 shows lesser impact in older sub‐Saharan Africans. Environmental findings highlight that exposure to air pollution, including nitrogen dioxide and particulate matter increases the likelihood of dementia. These findings highlight the role of genetic and environmental diversity in shaping dementia risk profiles. Strategies such as training health‐care professionals, enhancing funding for research, combating stigma through awareness campaigns, and fostering global collaborations are vital to ensure African representation in dementia studies. These efforts aim to improve the knowledge of dementia tailored to sub‐Saharan Africa's needs.Highlights: The ATP‐binding cassette subfamily A member 7 (ABCA7) gene is strongly associated with dementia risk, particularly in African American populations. Apolipoprotein E (APOE) ε4, a well‐established risk factor for Alzheimer's disease in Western populations, has a lesser impact in older sub‐Saharan Africans, suggesting unique genetic–environment interactions. Exposure to air pollutants, such as nitrogen dioxide and particulate matter, significantly increases dementia risk. The development of dementia in sub‐Saharan Africans is influenced by complex interactions between genetic predispositions and environmental exposures, emphasizing the need for tailored prevention strategies.
- 28 April 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (4)
Open AccessGenetic and environmental risk factors for dementia in African adults: A systematic review
Dementia, a leading cause of global mortality, disproportionately impacts sub‐Saharan Africans due to complex genetic and environmental interactions. This systematic review evaluated dementia risk factors among sub‐Saharan Africans, identifying significant genetic and environmental influences using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. The ATP‐binding cassette subfamily A member 7 (ABCA7) gene, linked to dementia in African Americans, and unique genetic variants like those in A‐kinase anchor protein 9 (AKAP9) and cytidine deaminase (CDA) genes, emerge as potential contributors. Conversely, apolipoprotein E (APOE) ε4 shows lesser impact in older sub‐Saharan Africans. Environmental findings highlight that exposure to air pollution, including nitrogen dioxide and particulate matter increases the likelihood of dementia. These findings highlight the role of genetic and environmental diversity in shaping dementia risk profiles. Strategies such as training health‐care professionals, enhancing funding for research, combating stigma through awareness campaigns, and fostering global collaborations are vital to ensure African representation in dementia studies. These efforts aim to improve the knowledge of dementia tailored to sub‐Saharan Africa's needs.Highlights: The ATP‐binding cassette subfamily A member 7 (ABCA7) gene is strongly associated with dementia risk, particularly in African American populations. Apolipoprotein E (APOE) ε4, a well‐established risk factor for Alzheimer's disease in Western populations, has a lesser impact in older sub‐Saharan Africans, suggesting unique genetic–environment interactions. Exposure to air pollutants, such as nitrogen dioxide and particulate matter, significantly increases dementia risk. The development of dementia in sub‐Saharan Africans is influenced by complex interactions between genetic predispositions and environmental exposures, emphasizing the need for tailored prevention strategies.
- Open Access
More than Just Protein Folding: The Epichaperome, Mastermind of the Cancer Cell
The epichaperome, a dynamic and integrated network of chaperone proteins, extends its roles beyond basic protein folding to protein stabilization and intracellular signal transduction to orchestrating a multitude of cellular processes critical for tumor survival. In this review, we explore the multifaceted roles of the epichaperome, delving into its diverse cellular locations, factors that modulate its formation and function, its liquid–liquid phase separation, and the key signaling and crosstalk pathways it regulates, including cellular metabolism and intracellular signal transduction. We further highlight techniques for isolating and identifying epichaperome networks, pitfalls, and opportunities. Further, we review the profound implications of the epichaperome for cancer treatment and therapy design, underscoring the need for strategic engineering that hinges on a comprehensive insight into the comprehensive structure and workings of the epichaperome across the heterogeneous cell subpopulations in the tumor milieu. By presenting a holistic view of the epichaperome’s functions and mechanisms, we aim to underscore its potential as a key target for novel anti-cancer strategies, revealing that the epichaperome is not merely a piece of protein folding machinery but a mastermind that facilitates the malignant phenotype.
Open AccessMore than Just Protein Folding: The Epichaperome, Mastermind of the Cancer Cell
The epichaperome, a dynamic and integrated network of chaperone proteins, extends its roles beyond basic protein folding to protein stabilization and intracellular signal transduction to orchestrating a multitude of cellular processes critical for tumor survival. In this review, we explore the multifaceted roles of the epichaperome, delving into its diverse cellular locations, factors that modulate its formation and function, its liquid–liquid phase separation, and the key signaling and crosstalk pathways it regulates, including cellular metabolism and intracellular signal transduction. We further highlight techniques for isolating and identifying epichaperome networks, pitfalls, and opportunities. Further, we review the profound implications of the epichaperome for cancer treatment and therapy design, underscoring the need for strategic engineering that hinges on a comprehensive insight into the comprehensive structure and workings of the epichaperome across the heterogeneous cell subpopulations in the tumor milieu. By presenting a holistic view of the epichaperome’s functions and mechanisms, we aim to underscore its potential as a key target for novel anti-cancer strategies, revealing that the epichaperome is not merely a piece of protein folding machinery but a mastermind that facilitates the malignant phenotype.
- Open Access
- 25 February 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (2) , e1885
Cognizance and mitigation of falsified immunization documentation: Analyzing the consequences for public health in Nigeria, with a focus on counterfeited COVID‐19 vaccination cards: A case report
Background and Aims: The global immunization campaign against COVID‐19 has mandated vaccination certificates, leading to a surge in fake documentation. In Nigeria, the proliferation of counterfeit COVID‐19 vaccination cards, facilitated by unscrupulous health workers, raises critical public health concerns. This research spotlights various forms of this malpractice, analyzes the factors contributing to the circulation of fake vaccination cards, their implications on public health, and provides recommendations for addressing the issue. Methods: Extensive literature review and analysis were conducted to investigate the emergence of fake COVID‐19 vaccination cards in Nigeria. Perspectives from health workers and reports from reputable undercover investigations were examined to identify factors contributing to the circulation of fraudulent records. The research also delved into corruption within the health sector and the impact of low salaries on healthcare workers. Additionally, global instances of fake vaccination cards were explored to provide a comprehensive understanding of the issue. Results: Healthcare workers' vaccine hesitancy, corruption, and inadequate salaries were identified as key contributors to the circulation of fake vaccination cards in Nigeria. Instances of health workers accepting bribes to issue cards without administering vaccines were uncovered. The implications on public health included threats to herd immunity, compromised disease surveillance, erosion of public trust, and reinforcement of vaccine hesitancy. The research also highlighted global challenges with fake vaccination cards, emphasizing the need for international cooperation. Conclusion: Fake vaccination cards in Nigeria poses challenges to public health, affecting the reliability of immunization data and jeopardizing disease control efforts. It is crucial to strengthen healthcare worker engagement, tackle corruption through increased transparency and improved policies, and implement digital vaccination verification systems. International collaboration is essential to establish standardized security measures and verification checkpoints. Addressing flawed vaccination records requires urgent action to enhance vaccination efforts, and safeguard the population from the resurgence of vaccine‐preventable diseases.
- 25 February 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (2) , e1885
Open AccessCognizance and mitigation of falsified immunization documentation: Analyzing the consequences for public health in Nigeria, with a focus on counterfeited COVID‐19 vaccination cards: A case report
Background and Aims: The global immunization campaign against COVID‐19 has mandated vaccination certificates, leading to a surge in fake documentation. In Nigeria, the proliferation of counterfeit COVID‐19 vaccination cards, facilitated by unscrupulous health workers, raises critical public health concerns. This research spotlights various forms of this malpractice, analyzes the factors contributing to the circulation of fake vaccination cards, their implications on public health, and provides recommendations for addressing the issue. Methods: Extensive literature review and analysis were conducted to investigate the emergence of fake COVID‐19 vaccination cards in Nigeria. Perspectives from health workers and reports from reputable undercover investigations were examined to identify factors contributing to the circulation of fraudulent records. The research also delved into corruption within the health sector and the impact of low salaries on healthcare workers. Additionally, global instances of fake vaccination cards were explored to provide a comprehensive understanding of the issue. Results: Healthcare workers' vaccine hesitancy, corruption, and inadequate salaries were identified as key contributors to the circulation of fake vaccination cards in Nigeria. Instances of health workers accepting bribes to issue cards without administering vaccines were uncovered. The implications on public health included threats to herd immunity, compromised disease surveillance, erosion of public trust, and reinforcement of vaccine hesitancy. The research also highlighted global challenges with fake vaccination cards, emphasizing the need for international cooperation. Conclusion: Fake vaccination cards in Nigeria poses challenges to public health, affecting the reliability of immunization data and jeopardizing disease control efforts. It is crucial to strengthen healthcare worker engagement, tackle corruption through increased transparency and improved policies, and implement digital vaccination verification systems. International collaboration is essential to establish standardized security measures and verification checkpoints. Addressing flawed vaccination records requires urgent action to enhance vaccination efforts, and safeguard the population from the resurgence of vaccine‐preventable diseases.
- Open Access
- 2 December 2021
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 1 (12) , e0000052
Prevalence and determinants of low testosterone levels in men with type 2 diabetes mellitus; a case-control study in a district hospital in Ghana
Diabetes mellitus, an endocrine disorder, has been implicated in many including hypogonadism in men. Given the fact that diabetes mellitus is becoming a fast-growing epidemic and the morbidity associated with it is more disabling than the disease itself. This study sought to assess the prevalence of low testosterone levels and predictors in type 2 diabetes mellitus patients and non-diabetic men in a district hospital in Ghana. This hospital-based case-control study comprised 150 type 2 diabetics and 150 healthy men. A pre-structured questionnaire and patient case notes were used to document relevant demographic and clinical information. Venous blood sample of about 6 ml was taken to measure FBS, HbA1c, FSH, LH, and testosterone levels. All data were analyzed using STATA version 12 (STATA Corporation, Texas, USA). The overall hypogonadism in the study population was 48% (144/300). The prevalence of hypogonadism in type 2 diabetic subjects was almost three times more than in healthy men (70.7% vs 25.3%). The odds of having hypogonadism was lower in the men with normal weight and overweight with their underweight counterparts (AOR = 0.33, 95% CI; 0.12–0.96, p = 0.042) and (AOR = 0.29, 95% CI; 0.10–0.84, p = 0.023) respectively. Also, the odds of suffering from hypogonadism was lower in non-smokers compared with smokers (AOR: 0.16, 95% CI; 0.05–0.58, p = 0.005). Participants who were engaged in light (AOR: 0.29, 95% CI; 0.14–0.61, p = 0.001), moderate (AOR: 0.26, 95% CI; 0.13–0.54, p<0.001) and heavy (AOR: 0.25, 95% CI; 0.10–0.67, p = 0.006) leisure time activities had lower odds hypogonadal compared to those engaged in sedentary living. Type 2 diabetic men have high incidence of hypogonadism, irrespective of their baseline clinical, lifestyle or demographic characteristics. Smoking and sedentary lifestyle and BMI were associated with hypogonadism in the study population. Routine testosterone assessment and replacement therapy for high risk patients is recommended to prevent the detrimental effect of hypogonadism in diabetic men.
- 2 December 2021
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 1 (12) , e0000052
Open AccessPrevalence and determinants of low testosterone levels in men with type 2 diabetes mellitus; a case-control study in a district hospital in Ghana
Diabetes mellitus, an endocrine disorder, has been implicated in many including hypogonadism in men. Given the fact that diabetes mellitus is becoming a fast-growing epidemic and the morbidity associated with it is more disabling than the disease itself. This study sought to assess the prevalence of low testosterone levels and predictors in type 2 diabetes mellitus patients and non-diabetic men in a district hospital in Ghana. This hospital-based case-control study comprised 150 type 2 diabetics and 150 healthy men. A pre-structured questionnaire and patient case notes were used to document relevant demographic and clinical information. Venous blood sample of about 6 ml was taken to measure FBS, HbA1c, FSH, LH, and testosterone levels. All data were analyzed using STATA version 12 (STATA Corporation, Texas, USA). The overall hypogonadism in the study population was 48% (144/300). The prevalence of hypogonadism in type 2 diabetic subjects was almost three times more than in healthy men (70.7% vs 25.3%). The odds of having hypogonadism was lower in the men with normal weight and overweight with their underweight counterparts (AOR = 0.33, 95% CI; 0.12–0.96, p = 0.042) and (AOR = 0.29, 95% CI; 0.10–0.84, p = 0.023) respectively. Also, the odds of suffering from hypogonadism was lower in non-smokers compared with smokers (AOR: 0.16, 95% CI; 0.05–0.58, p = 0.005). Participants who were engaged in light (AOR: 0.29, 95% CI; 0.14–0.61, p = 0.001), moderate (AOR: 0.26, 95% CI; 0.13–0.54, p<0.001) and heavy (AOR: 0.25, 95% CI; 0.10–0.67, p = 0.006) leisure time activities had lower odds hypogonadal compared to those engaged in sedentary living. Type 2 diabetic men have high incidence of hypogonadism, irrespective of their baseline clinical, lifestyle or demographic characteristics. Smoking and sedentary lifestyle and BMI were associated with hypogonadism in the study population. Routine testosterone assessment and replacement therapy for high risk patients is recommended to prevent the detrimental effect of hypogonadism in diabetic men.
- 21 September 2021
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (11) , 3881-3886
Non-life-threatening adverse reactions from COVID-19 vaccine; a cross-sectional study with self-reported symptoms among Ghanaian healthcare workers
Health-care professionals in Ghana were among the prioritized high-risk groups to be administered with the initial supply of Oxford/AstraZeneca vaccine procured by the Government of Ghana. This study sought to assess and identify the determinants of COVID-19 vaccine short-term side effects among health-care workers. A cross-sectional study was conducted on 654 Ghanaian healthcare workers between 16th March and 5th May 2021. The study included health-care workers in registered health settings, who had been vaccinated against COVID-19 and consented to participate in the survey. Descriptive statistics, binary and multivariable logistic regression analyses were executed using SPSS version 22 at p < .05. The findings revealed that, 528 (80.7%) of the participants experienced adverse reactions, which lasted between 0 and 2 days among, 347 (53.1%) of the study participants. The most reported adverse reactions were general body weakness, 434 (32.0%), headache 371 (27.3%), and fever, 257 (19.1%). Health workers aged 35–39 and 40–44 years had lower odds of adverse reactions compared with those aged 25–29 years (aOR: 0.34, 95% C.I. 0.186,0.621, p < .001) and (aOR: 0.42, 95% C.I. 0.201,0.890, p = .023). Taking analgesics before vaccination decreased the likelihood of adverse reactions (aOR: 0.28, 95% C.I. 0.185,0.427, p < .001). High prevalence of adverse reactions was found among the healthcare workers, however short-lived. The most reported systemic adverse reactions were general body weakness, headache, and fever. We recommend intensification of campaigns on COVID-19 vaccines and their associated adverse effects to avoid the negative implication on uptake among the healthcare workers and the general population.
- 21 September 2021
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (11) , 3881-3886
Non-life-threatening adverse reactions from COVID-19 vaccine; a cross-sectional study with self-reported symptoms among Ghanaian healthcare workers
Health-care professionals in Ghana were among the prioritized high-risk groups to be administered with the initial supply of Oxford/AstraZeneca vaccine procured by the Government of Ghana. This study sought to assess and identify the determinants of COVID-19 vaccine short-term side effects among health-care workers. A cross-sectional study was conducted on 654 Ghanaian healthcare workers between 16th March and 5th May 2021. The study included health-care workers in registered health settings, who had been vaccinated against COVID-19 and consented to participate in the survey. Descriptive statistics, binary and multivariable logistic regression analyses were executed using SPSS version 22 at p < .05. The findings revealed that, 528 (80.7%) of the participants experienced adverse reactions, which lasted between 0 and 2 days among, 347 (53.1%) of the study participants. The most reported adverse reactions were general body weakness, 434 (32.0%), headache 371 (27.3%), and fever, 257 (19.1%). Health workers aged 35–39 and 40–44 years had lower odds of adverse reactions compared with those aged 25–29 years (aOR: 0.34, 95% C.I. 0.186,0.621, p < .001) and (aOR: 0.42, 95% C.I. 0.201,0.890, p = .023). Taking analgesics before vaccination decreased the likelihood of adverse reactions (aOR: 0.28, 95% C.I. 0.185,0.427, p < .001). High prevalence of adverse reactions was found among the healthcare workers, however short-lived. The most reported systemic adverse reactions were general body weakness, headache, and fever. We recommend intensification of campaigns on COVID-19 vaccines and their associated adverse effects to avoid the negative implication on uptake among the healthcare workers and the general population.